Accessibility Menu
Zimmer Biomet logo

Zimmer Biomet(NYSE) ZBH

Market Cap$18.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2001)+279%
5 Year-30%
1 Year-1%
1 Month+10%
$97.62
+1.11%
+1.07Today
After hours$97.23-$0.39 (-0.40%)
Zimmer Biomet last closing stock price
MetricPriceDate
Last closeUSD 96.552026-08-07
Zimmer Biomet stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.79%USD 93.932026-07-31
1 month+10.27%USD 87.562026-07-08
3 month+17.58%USD 82.112026-05-08
Year to date+7.95%USD 89.442025-12-31
1 year-0.88%USD 97.412025-08-07
3 year-20.48%USD 121.422023-08-08
5 year-30.25%USD 138.432021-08-06
Since inception+278.77%USD 25.492001-07-25

Zimmer Biomet Financials at a Glance

Market Cap

$18.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$8.51B

Net Income (TTM)

$806.80M

EPS (TTM)

$4.11

P/E Ratio

23.50

Dividend

$0.96

Beta (Volatility)

0.60 (Low)

Price

$97.62

Volume

3,278,455

Open

$96.66

Previous Close

$97.78

Daily Range

$95.46 - $97.85

52-Week Range

$79.12 - $108.29

Estimated Earnings Date

Nov 4, 2026

ZBH News

Foolcom-Featured.png

Zimmer Biomet (ZBH) Q2 Revenue Jumps 7%

Motley Fool Markets TeamAug 7, 2025
senior couple running in park

1 More Excellent Reason to Love This Leading Healthcare Company

Jeffrey LittleMay 15, 2021
Hip replacement implant

How Zimmer Biomet Zoomed Past Wall Street's Third-Quarter Estimates

Keith SpeightsNov 6, 2020
GettyImages-1218158665

As Coronavirus Cases Climb, Here's 1 Stock to Buy and 1 to Avoid

Jason HawthorneOct 31, 2020
Copy of senior man talking to doctor holding clipboard medical expenses healthcare hospital

3 Cheap Surgical Stocks to Buy Now Before They Bounce Back

James HalleyJul 9, 2020
GettyImages-1000656954

Can Medical Device Stocks Help Rebuild Your Portfolio?

David HaenMar 24, 2020
man holding tablet with numbers projecting

How Zimmer Biomet Holdings Beat Expectations in Q4

Keith SpeightsFeb 4, 2020
Man holding hand out with chart going up

3 Large-Cap Healthcare Stocks Recently Hitting All-Time Highs: Are They Buys?

Keith SpeightsSep 12, 2019
Page 1

ZBH: Motley Fool Moneyball Superscore

62

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zimmer Biomet

Zimmer Biomet makes medical tools that help people move better and live with less pain. These products assist doctors in fixing damaged joints like knees and hips during surgery. The company also builds robotic systems that help surgeons perform procedures with higher precision.

What They Build

  • Knees: Replacement parts including femoral components and tibial trays for first-time and repair surgeries.
  • Hips: Devices designed to replace the ball and socket of the natural hip joint.
  • S.E.T. Portfolio: Products for sports medicine, biologics, extremities, and trauma; these accounted for roughly 23% of 2025 net sales.
  • Digital Robotics: Robotic technologies and data tools that help surgeons plan and perform bone surgeries.
  • Surgical Solutions: Bone cement and other tools used by hospitals to stabilize implants in the body.

Recent Strategic Moves

  • Acquired LVB Acquisition, Inc., the parent of Biomet, to expand its orthopaedic reconstructive offerings.
  • Launched a multi-year plan to turn independent sales agents into full-time employees in the U.S. market.
  • Introduced the ZBEdge platform to connect digital and robotic tools using artificial intelligence.
  • Completed the spinoff of ZimVie Inc. to focus resources on higher-priority growth operations.

What Makes Them Different

The company maintains a vast intellectual property portfolio with over 6,000 issued patents and applications. It operates a global network with major research hubs in the U.S., Canada, Switzerland, and China.

The Latest Financial Facts

  • Revenue reached $2.2 billion in Q4 2025, up 10.9% from Q4 2024.
  • Free cash flow grew to $668.7 million in Q4 2025, a 58.7% increase year-over-year.
  • Operating income fell to $287.8 million in Q4 2025, down 26% from the previous year.
  • Net income was $139.5 million in Q4 2025, a 41.8% decrease compared to Q4 2024.
  • Consignment sales accounted for approximately 85% of total net sales during 2025.

Evolution and Future Focus

Zimmer Biomet has transitioned from a traditional implant manufacturer into a technology-driven company using robotics and artificial intelligence. This shift focuses on connecting digital data with surgical tools to improve patient outcomes.

AI Generated • Apr 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

17,000

CEO

Ivan Tornos, Jr., MBA

Website

www.zimmerbiomet.com

Headquarters

Warsaw, IN 46580, US

ZBH Financials

Key Financial Metrics (TTM)

Gross Margin

69.87%

Operating Margin

15.73%

Net Income Margin

9.48%

Return on Equity

6.36%

Return on Capital

6.74%

Return on Assets

3.54%

Earnings Yield

4.26%

Dividend Yield

0.99%

Payout Ratio

29.16%

Stock Overview

Market Cap

$18.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

190.74M

Volume

3.28M

Avg. Volume

2.37M

Financials (TTM)

Gross Profit

$5.95B

Operating Income

$1.34B

EBITDA

$1.96B

Operating Cash Flow

$2.10B

Capital Expenditure

$151.70M

Free Cash Flow

$2.25B

Cash & ST Invst.

$410.00M

Total Debt

$7.48B

Zimmer Biomet Performance Analysis

Zimmer Biomet annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 6,939,900,0001.6%
20232023-12-31USD 7,394,200,0006.5%
20242024-12-31USD 7,678,600,0003.8%
20252025-12-31USD 8,231,500,0007.2%
Zimmer Biomet sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3.7%
Q42025-12-3112.1%
Q12026-03-31-7.0%
Q22026-06-304.3%
Zimmer Biomet annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.10-42.4%
20232023-12-31USD 4.88343.8%
20242024-12-31USD 4.43-9.2%
20252025-12-31USD 3.55-19.9%
Zimmer Biomet sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3050.6%
Q42025-12-31-39.7%
Q12026-03-3174.3%
Q22026-06-30-15.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.18B

+4.8%

Gross Profit

$1.54B

+3.8%

Gross Margin

70.81%

N/A

Market Cap

$18.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.08M

N/A

Employees

17,000

N/A

Net Income

$198.30M

+29.8%

EBITDA

$328.00M

-43.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$410.00M

-26.4%

Total Debt

$7.48B

-1.2%

Accounts Receivable

$1.77B

+9.8%

Inventory

$0.00

-100.0%

Long Term Debt

$6.28B

-7.0%

Short Term Debt

$1.20B

+46.5%

Return on Assets

3.54%

N/A

Return on Invested Capital

6.76%

N/A

Free Cash Flow

$716.70M

+140.4%

Operating Cash Flow

$807.20M

+113.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UTHRUnited Therapeutics Corporation
$529.66-1.70%
STESTERIS plc
$238.91+0.61%
SNNSmith & Nephew plc
$30.08-0.10%
INCYIncyte Corporation
$121.55+0.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$138.74+0.04%
ACHRArcher Aviation
$6.26+0.12%
NVDANvidia
$217.55-0.03%
INTCIntel
$97.52-0.04%

Questions About ZBH

What is the current price of Zimmer Biomet?

Zimmer Biomet is trading at $97.78 per share.

What is the 52-week range for Zimmer Biomet?

Over the past 52 weeks, Zimmer Biomet has traded between $79.12 and $108.29.

How much debt does Zimmer Biomet have?

As of the most recent reporting period, Zimmer Biomet reported total debt of $7.48B.

How much cash does Zimmer Biomet have on hand?

Zimmer Biomet reported $410.00M in cash and cash equivalents in its most recent financial results.

What is Zimmer Biomet’s dividend yield?

Zimmer Biomet currently has a dividend yield of 0.99%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services